HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Mirzapoiazova, T. Articles by Verin, A. D. Search for Related Content PubMed PubMed Citation Articles by Mirzapoiazova, T. Articles by Verin, A. D.

Suppression of endotoxin-induced inflammation by taxol

¹ Dept of Medicine, The University of Chicago, Chicago, IL, ² Dept of Medicine, Case Western Reserve University, Cleveland, OH, and ³ Vascular Biology Center, Medical College of Georgia, Augusta, GA, USA.

CORRESPONDENCE: A. D. Verin, Vascular Biology Center, CB-3210A, Medical College of Georgia, Augusta, GA 30912-2500, USA. Fax: 1 7067219799. E-mail: averin{at}mcg.edu

Keywords: Endotoxin, inflammation, lipopolysaccharide, lung injury, oedema, taxol

Received: November 27, 2006
Accepted May 9, 2007

The pathogenesis of acute lung injury includes transendothelial diapedesis of leukocytes into lung tissues and disruption of endothelial/epithelial barriers leading to protein-rich oedema. In vitro studies show that the microtubule network plays a role in the regulation of endothelial permeability as well as in neutrophil locomotion. It was hypothesised that the microtubule-stabilising agent, taxol, might attenuate inflammation and vascular leak associated with acute lung injury in vivo.

The effect of intravenously delivered taxol was assessed using a model of murine lung injury induced by intratracheal lipopolysaccharide (LPS) administration. Parameters of lung injury and inflammation were assessed 18 h after treatment.

Intravenously delivered taxol significantly reduced inflammatory histological changes in lung parenchyma and parameters of LPS-induced inflammation: infiltration of proteins and inflammatory cells into bronchoalveolar lavage fluid, lung myeloperoxidase activity, and extravasation of Evans blue-labelled albumin into lung tissue. Taxol alone (in the absence of LPS) had no appreciable effect on these parameters. In addition to lung proteins, intravenous taxol reduced accumulation of leukocytes in ascitic fluid in a model of LPS-induced peritonitis.

Taken together, the present data demonstrate that microtubule stabilisation with taxol systemically attenuates lipopolysaccharide-induced inflammation and vascular leak.